Showing results (241-250 of 2,560) with videos related to
Sort By:
Pageof 256
Advanced Drug Delivery Reviews|October 9, 2008
Active targeting schemes for nanoparticle systems in cancer therapeuticsJames D Byrne, Tania Betancourt, Lisa Brannon-PeppasLangmuir : the ACS Journal of Surfaces and Colloids|November 30, 2006
Conducting metallopolymers based on azaferrocenePaul D Byrne, Peter Müller, Timothy M SwagerAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 3, 2014
CKD and nonalcoholic fatty liver diseaseGiovanni Targher, Michel B Chonchol, Christopher D ByrneAMA Journal of Ethics|September 4, 2020
Should the Location of a Patient's Home Inform Physicians' Opioid Prescription Practices?Jennifer D Byrne, Katie S Clancy, Isabell CiszewskiQJM : Monthly Journal of the Association of Physicians|January 24, 2015
Patient risk profiling in acute medicine: the way forward?R Conway, D Byrne, D O'Riordan, et al.The Proceedings of the Nutrition Society|August 7, 2022
Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal functionJosh Bilson, Jaswinder K Sethi, Christopher D ByrneAcute Medicine|February 22, 2023
Blood Culture and Troponin Testing in Suspected Bacteraemic Admissions - Example of Risk Stratification Based on Clinical TestingR Conway, D Byrne, D O'Riordan, et al.Nature Communications|June 14, 2016
Mesoscale atmosphere ocean coupling enhances the transfer of wind energy into the oceanD Byrne, M Münnich, I Frenger, et al.QJM : Monthly Journal of the Association of Physicians|August 1, 2023
Short- and long-term mortality following acute medical admissionR Conway, D Byrne, D O'Riordan, et al.Current Pharmaceutical Design|February 1, 2020
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)Michael P Johnston, Janisha Patel, Christopher D ByrnePageof 256